A drug derived from cannabis reduces certain epilepsy patients’ risk of a fit by nearly 50 percent, new research shows. Sufferers of Lennox-Gastaut syndrome, which is a rare, severe form of the condition, are 43.9 percent less likely to have a drop seizure if they take the medication every day for 14 weeks … Read More
The post Cannabis drug slashes the risk of an epileptic fit by nearly 50%, study finds appeared first on Dagga Magazine.